Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

VIOX FORMULA #V1839

NFPA

PRODUCT USE

Electronic glass frit powder.

SYNONYMS

electronic, glass, frit, powder

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Harmful by inhalation and if swallowed.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual.  Ingestion of soluble barium compounds may result in ulceration of the mucous membranes of the gastrointestinal tract, tightness in the muscles of the face and neck, gastroenteritis, vomiting, diarrhea, muscular tremors and paralysis, anxiety, weakness, labored breathing, cardiac irregularity due to contractions of smooth striated and cardiac muscles (often violent and painful), slow irregular pulse, hypertension, convulsions and respiratory failure.  

EYE

  There is some evidence to suggest that this material can causeeye irritation and damage in some persons.  

SKIN

  Skin contact is not thought to produce harmful health effects (as classified using animal models). Systemic harm, however, has been identified following exposure of animals by at least one other route and the material may still produce health damage following entry through wounds, lesions or abrasions. Good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  Inhalation of dusts, generated by the material, during the course of normalhandling, may be harmful.  There is some evidence to suggest that the material can cause respiratory irritation in some persons. The body's response to such irritation can cause further lung damage.  Barium fumes are respiratory irritants. Over-exposure to barium dusts and fume may result in rhinitis, frontal headache, wheezing, laryngeal spasm, salivation and anorexia. Long term effects include nervous disorders and adverse effects on the heart, circulatory system and musculature. Heavy exposures may result in a benign pneumoconiosis.  Effects on lungs are significantly enhanced in the presence of respirableparticles.  

CHRONIC HEALTH EFFECTS

  Repeated or long-term occupational exposure is likely to produce cumulative health effects involving organs or biochemical systems.  Ample evidence exists that developmental disorders are directlycaused by human exposure to the material.  Ample evidence from experiments exists that there is a suspicionthis material directly reduces fertility.  Repeated exposures, in an occupational setting, to high levels of fine- divided dusts may produce a condition known as pneumoconiosis which is the lodgement of any inhaled dusts in the lung irrespective of the effect. This is particularly true when a significant number of particles less than 0.5 microns (1/50,000 inch), are present. Lung shadows are seen in the X-ray. Symptoms of pneumoconiosis may include a progressive dry cough, shortness of breath on exertion, increased chest expansion, weakness and weight loss. As the disease progresses the cough produces a stringy mucous, vital capacity decreases further and shortness of breath becomes more severe. Pneumoconiosis is the accumulation of dusts in the lungs and the tissue reaction in its presence. It is further classified as being of noncollagenous or collagenous types. Noncollagenous pneumoconiosis, the benign form, is identified by minimal stromal reaction, consists mainly of reticulin fibres, an intact alveolar architecture and is potentially reversible.  Barium compounds may cause high blood pressure, airway irritation and damage the liver, spleen and bone marrow. Prolonged exposure may cause a lung inflammation and scarring. Symptoms of this include a worsening dry cough, shortness of breath on exertion, increased chest expansion and weakness. Stringy phlegm in the cough appears later, with more difficulty in breathing and a further loss of lung capacity. Barium sulfate does not cause permanent scarring of the lungs.